Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
61Cu-NU101 for Prostate Cancer Imaging
NCT07635524Phase 2Not yet recruiting
- Sponsor
- Hoag Memorial Hospital Presbyterian
- Start
- Aug 2026
- Primary completion
- Aug 2028
- Countries
- 1
01
Overview
A Phase 2 trial of 61Cu-NU101 in prostate cancer (PCa), sponsored by Hoag Memorial Hospital Presbyterian. Planned start Aug 2026; status: not yet recruiting.
02
Drugs
61Cu-NU101
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT07635524.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07635524.